Croatia vs New Zealand: Share of the population living with HIV receiving antiretroviral therapy
Croatia
84.9%
in 2024
New Zealand
84.2%
in 2024
Croatia rank
39th
New Zealand rank
41st
Share of the population living with HIV receiving antiretroviral therapy over time
- Croatia
- New Zealand
How they compare
Croatia currently reports 84.9% against 84.2% in New Zealand, a difference of 0.7%.
The two have swapped places 3 times across 35 shared years of data; in 1990 it was New Zealand ahead.
Croatia ranks 39th and New Zealand ranks 41st of 149 countries.
Across the 4 decades both report, Croatia averaged higher in 1 and New Zealand in 3.
Head to head by decade
| Decade | Croatia | New Zealand | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 6.5% | 13.4% | 7.0% | New Zealand |
| 2000s | 32.5% | 43.2% | 10.7% | New Zealand |
| 2010s | 59.9% | 64.2% | 4.3% | New Zealand |
| 2020s | 80.9% | 79.2% | 1.8% | Croatia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of the population living with hiv receiving antiretroviral therapy, Croatia or New Zealand?
- Croatia, at 84.9% against 84.2% in New Zealand as of 2024.
- What is the difference in share of the population living with hiv receiving antiretroviral therapy between Croatia and New Zealand?
- 0.7%, with Croatia ahead.
- How many years of comparable data are there for Croatia and New Zealand?
- 35 years are reported by both, from 1990 to 2024.
- How do Croatia and New Zealand rank globally for share of the population living with hiv receiving antiretroviral therapy?
- Croatia ranks 39th and New Zealand ranks 41st of 149 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as Share of the population living with HIV receiving antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of individuals diagnosed with HIV who are currently receiving antiretroviral therapy. This is the central estimate.